{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T01:10:53Z","timestamp":1794964253529,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.xcrm.2024.101392","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T15:28:12Z","timestamp":1706282892000},"page":"101392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus"],"prefix":"10.1016","volume":"5","author":[{"given":"Robert W.","family":"Cross","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla A.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Woolsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek N.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoriya","family":"Borisevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle N.","family":"Agans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Deer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Dobias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa C.","family":"Fears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan B.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Garry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Branco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0858-1877","authenticated-orcid":false,"given":"Thomas W.","family":"Geisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101392_bib1","unstructured":"World Health Organization. Lassa Fever. https:\/\/www.who.int\/health-topics\/lassa-fever#tab=tab_1."},{"key":"10.1016\/j.xcrm.2024.101392_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2105\/AJPH.2017.304186","article-title":"Mortality Among Confirmed Lassa Fever Cases During the 2015-2016 Outbreak in Nigeria","volume":"108","author":"Buba","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.xcrm.2024.101392_bib3","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/infdis\/155.3.445","article-title":"A case-control study of the clinical diagnosis and course of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/infdis\/155.3.437","article-title":"A prospective study of the epidemiology and ecology of Lassa fever","volume":"155","author":"McCormick","year":"1987","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib5","doi-asserted-by":"crossref","first-page":"S783","DOI":"10.1093\/clinids\/11.Supplement_4.S783","article-title":"Clinical features of Lassa fever in Liberia","volume":"11","author":"Frame","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1089\/15303660160025903","article-title":"Lassa fever in Guinea: I. Epidemiology of human disease and clinical observations","volume":"1","author":"Bausch","year":"2001","journal-title":"Vector Borne Zoonotic Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib7","first-page":"1","article-title":"Lassa fever in West African sub-region: an overview","volume":"44","author":"Ogbu","year":"2007","journal-title":"J.\u00a0Vector Borne Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib8","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/inthealth\/ihac076","article-title":"Lassa fever cases suffer from severe underreporting based on reported fatalities","volume":"15","author":"Simons","year":"2023","journal-title":"Int. Health"},{"key":"10.1016\/j.xcrm.2024.101392_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.185.4147.263","article-title":"Lassa Virus Isolation from Mastomys natalensis Rodents during an Epidemic in Sierra Leone","volume":"185","author":"Monath","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101392_bib10","first-page":"27","article-title":"Understanding the transmission pathways of Lassa fever: A mathematical modeling approach","volume":"8","author":"Madueme","year":"2023","journal-title":"Infect. Dis. Model."},{"key":"10.1016\/j.xcrm.2024.101392_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41579-022-00789-8","article-title":"Lassa fever \u2014 the road ahead","volume":"21","author":"Garry","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.xcrm.2024.101392_bib12","unstructured":"Centers for Disease Control and Prevention (U.S.). Lassa Fever: Transmission. https:\/\/www.cdc.gov\/vhf\/lassa\/transmission\/index.html."},{"key":"10.1016\/j.xcrm.2024.101392_bib13","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jmv.1890140402","article-title":"Effect of environmental factors on aerosol-induced lassa virus infection","volume":"14","author":"Stephenson","year":"1984","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.xcrm.2024.101392_bib14","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/pathogens9090680","article-title":"Survival of Lassa Virus in Blood and Tissue Culture Media and in a Small Particle Aerosol","volume":"9","author":"Smither","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.xcrm.2024.101392_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111094","article-title":"A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against heterologous lethal Lassa fever","volume":"40","author":"Cross","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2024.101392_bib16","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/s41467-023-37050-6","article-title":"Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys","volume":"14","author":"Mateo","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101392_bib18","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/nm.4396","article-title":"Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa fever","volume":"23","author":"Mire","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101392_bib19","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2304876120","article-title":"A human monoclonal antibody combination rescues nonhuman primates from advanced disease caused by the major lineages of Lassa virus","volume":"120","author":"Cross","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101392_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/v9110319","article-title":"Development of a Lethal Intranasal Exposure Model of Ebola Virus in the Cynomolgus Macaque","volume":"9","author":"Alfson","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2024.101392_bib21","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1093\/infdis\/jiz391","article-title":"An intranasal exposure model of lethal Nipah virus infection in African green monkeys","volume":"221","author":"Geisbert","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12985-020-01396-w","article-title":"Intranasal exposure of African green monkeys to SARS-CoV-2 results in acute phase pneumonia with shedding and lung injury still present in the early convalescence phase","volume":"17","author":"Cross","year":"2020","journal-title":"Virol. J."},{"key":"10.1016\/j.xcrm.2024.101392_bib23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI131958","article-title":"Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and death","volume":"130","author":"Cross","year":"2020","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2024.101392_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1743-422X-8-205","article-title":"Pathogenesis of Lassa fever in cynomolgus macaques","volume":"8","author":"Hensley","year":"2011","journal-title":"Virol. J."},{"key":"10.1016\/j.xcrm.2024.101392_bib25","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"F\u00f6rster","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2024.101392_bib26","unstructured":"World Health Organization. Prioritizing Diseases for Research and Development in Emergency Contexts. https:\/\/www.who.int\/activities\/prioritizing-diseases-for-research-and-development-in-emergency-contexts."},{"key":"10.1016\/j.xcrm.2024.101392_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1128\/jcm.19.3.429-431.1984","article-title":"Protective efficacies of live attenuated and formaldehyde-inactivated Venezuelan equine encephalitis virus vaccines against aerosol challenge in hamsters","volume":"19","author":"Jahrling","year":"1984","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.xcrm.2024.101392_bib28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1863-2378.2007.01063.x","article-title":"An aerosolized Brucella spp. challenge model for laboratory animals","volume":"54","author":"Olsen","year":"2007","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.xcrm.2024.101392_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jpids\/piaa079","article-title":"A Rosetta Stone for Understanding Infectious Drops and Aerosols","volume":"9","author":"Milton","year":"2020","journal-title":"J.\u00a0Pediatric Infect. Dis. Soc."},{"key":"10.1016\/j.xcrm.2024.101392_bib30","series-title":"Aerosol technology: Properties, behavior, and measurement of airborne particles","first-page":"233","article-title":"Respiratory Deposition","author":"Hinds","year":"1999"},{"key":"10.1016\/j.xcrm.2024.101392_bib31","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/v12060593","article-title":"Natural History of Aerosol Induced Lassa Fever in Non-human Primates","volume":"12","author":"Downs","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2024.101392_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001687","article-title":"Why does viral RNA sometimes persist after recovery from acute infections?","volume":"20","author":"Griffin","year":"2022","journal-title":"PLoS Biol."},{"key":"10.1016\/j.xcrm.2024.101392_bib33","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/bmj.285.6347.1001","article-title":"A case of Lassa fever: clinical and virological findings","volume":"285","author":"Emond","year":"1982","journal-title":"Br. Med. J."},{"key":"10.1016\/j.xcrm.2024.101392_bib34","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/infdis\/jix201","article-title":"A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses","volume":"215","author":"McElroy","year":"2017","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib35","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/cid\/cix406","article-title":"Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever","volume":"65","author":"Raabe","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib36","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S2666-5247(21)00178-6","article-title":"Virus persistence after recovery from acute Lassa fever in Nigeria: a 2-year interim analysis of a prospective longitudinal cohort study","volume":"3","author":"Thielebein","year":"2022","journal-title":"Lancet. Microbe"},{"key":"10.1016\/j.xcrm.2024.101392_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243766","article-title":"Ophthalmic manifestations and vision impairment in Lassa fever survivors","volume":"15","author":"Li","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.xcrm.2024.101392_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006187","article-title":"Lassa fever\u2013induced sensorineural hearing loss: A neglected public health and social burden","volume":"12","author":"Mateer","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib39","doi-asserted-by":"crossref","first-page":"ofz512","DOI":"10.1093\/ofid\/ofz512","article-title":"Sequelae of Lassa Fever: Postviral Cerebellar Ataxia","volume":"6","author":"Ezeomah","year":"2019","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib40","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.xcrm.2024.101392_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010433","article-title":"A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge","volume":"16","author":"Woolsey","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.xcrm.2024.101392_bib42","doi-asserted-by":"crossref","first-page":"S436","DOI":"10.1093\/infdis\/jiz613","article-title":"Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity","volume":"221","author":"Prasad","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib43","first-page":"jiad157","article-title":"A highly attenuated pan-filovirus VesiculoVax vaccine rapidly protects nonhuman primates against Marburg virus and three species of Ebolavirus","author":"Woolsey","year":"2023","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2024.101392_bib44","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T11:00:11Z","timestamp":1733223611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2666379124000016"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101392","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoclonal antibody therapy protects nonhuman primates against mucosal exposure to Lassa virus","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101392","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"101392"}}